Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes 56:594-603, 2007
DOI: 10.2337/db06-0779
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, R.
Right arrow Articles by Spinas, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, R.
Right arrow Articles by Spinas, G. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Superiority of Small Islets in Human Islet Transplantation

Roger Lehmann1, Richard A. Zuellig1, Patrick Kugelmeier2,3, Philipp B. Baenninger1, Wolfgang Moritz3,4, Aurel Perren5, Pierre-Alain Clavien5, Markus Weber3,4, and Giatgen A. Spinas1,6

1 Department of Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland
2 Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland
3 Zurich Center for Integrative Human Physiology, Zurich, Switzerland
4 Department of Visceral Surgery, University Hospital Zurich, Zurich, Switzerland
5 Department of Pathology, University Hospital Zurich, Zurich, Switzerland
6 Competence Center for Systems Physiology and Metabolic Diseases, Zurich, Switzerland

Address correspondence and reprint requests to R. Lehmann, MD, Head of Clinical Islet Transplantation Program, Department of Endocrinology and Diabetes, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. E-mail: roger.lehmann{at}usz.ch

Abbreviations: IEQ, islet equivalent; TUNEL, terminal dUTP nick-end labeling

Many factors influence the outcome of islet transplantation. As islets in the early posttransplant setting are supplied with oxygen by diffusion only and are in a hypoxic state in the portal system, we tested whether small human islets are superior to large islets both in vitro and in vivo. We assessed insulin secretion of large and small islets and quantified cell death during hypoxic conditions simulating the intraportal transplant environment. In the clinical setting, we analyzed the influence of transplanted islet size on insulin production in patients with type 1 diabetes. Our results provide evidence that small islets are superior to large islets with regard to in vitro insulin secretion and show a higher survival rate during both normoxic and hypoxic culture. Islet volume after 48 h of hypoxic culture decreased to 25% compared with normoxic culture at 24 h due to a preferential loss of large islets. In human islet transplantation, the isolation index (islet volume as expressed in islet equivalents/islet number), or more simply the islet number, proved to be more reliable to predict stimulated C-peptide response compared with islet volume. Thus, islet size seems to be a key factor determining human islet transplantation outcome.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.